CNS-directed chemotherapy including high-dose chemotherapy with autologous stem cell transplantation (HD-ASCT) for CNS relapse of aggressive lymphomas: Final analysis of a phase II study.

Authors

null

Agnieszka Korfel

Department of Hematology and Oncology, Charite Campus Benjamin Franklin, Berlin, Germany

Agnieszka Korfel , Gerald Illerhaus , Mathias Haenel , Robert Moehle , Roland Schroers , Thomas Elter , Marcel Reiser , Martin H. Dreyling , Jan Eucker , Christian Winfried Scholz , Bernd Metzner , Alexander Roeth , Josef Birkmann , Uwe S. Schlegel , Peter Martus , Eckhard Thiel , Lars Fischer

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Lymphoma and Plasma Cell Disorders

Track

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Sub Track

Lymphoma

Clinical Trial Registration Number

NCT01148173

Citation

J Clin Oncol 30, 2012 (suppl; abstr 8031)

DOI

10.1200/jco.2012.30.15_suppl.8031

Abstract #

8031

Poster Bd #

11

Abstract Disclosures